Monitoring CD27 to evaluate Mycobacterium tuberculosis activity in HIV-1 infected individuals in vivo
Schurtz A, Haule A, Reither K, Ngwenyama N, Rachow A, Meyerhans A, Maboko L, Koup RA, Hoelscher M and Geldmacher C
PLOS one, in press September 2011
Pathogen-specific CD4 T cell loss during HIV infection: Impact of T cell phenotype and function.
Geldmacher C and Koup RA
Submitted to Trends in Immunology, Nov. 2011
Pathogen-prevalence may determine maintenance of antigen-specific T-cell responses in HIV-infected individuals
Alexandra SCHUETZ2,3,4*, Jan DIRKS1*, Urban SESTER3, Antelmo HAULE4, Nyanda ELIAS4, Christof GELDMACHER4,5, Erica SANGA4, Leonard MABOKO4, Klaus REITHER5, Michael HOELSCHER5, Andreas MEYERHANS2,6, and Martina SESTER1
Submitted to AIDS Oct., 2011
Preferential infection and depletion of Mycobacterium tuberculosis (MTB)-specific CD4 T cells after HIV-1 infection
Geldmacher C*, Ngwenyama N*, Schuetz A, Petrovas C, Reither K, Heeregrave EJ, Casazza J, Ambrozak D, Louder M, Ampofo W, Pollakis G, Hill B, Sanga E, Saathoff E, Maboko L, Roederer M, Paxton WA, Hoelscher M and Koup RA
J Exp Med. 2010 Dec 20;207(13):2869-81
* Geldmacher & Ngwenyama are Co-first authors
A phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-Uninfected East Africans (RV 172).
Kibuuka H, Kimutai R, Maboko L, Sawe F, Schunk MS, Kroidl A, Shaffer D, Eller LA, Kibaya R, Eller MA, Schindler KB, Schuetz A, Millard M, Kroll J, Dally L, Hoelscher M, Bailer R, Cox JH, Marovich M, Birx DL, Graham BS, Michael NL, de Souza MS, Robb ML
J Infect Dis. 2010 Feb 15;201(4):600-7
Minor viral and host genetic polymorphisms can dramatically impact the biological outcome of an epitope-specific CD8 T cell response
Geldmacher C, Metzler IS, Tovanabutra S, Asher TE, Gostick E, Ambrozak DR, Petrovas C, Schuetz A, Ngwenyama N, Kijak G, Maboko L, Hoelscher M, McCutchan F, Price DA, Douek DC and Koup RA
Blood. 2009 Aug 20;114(8):1553-62.
Reply to Robert Wallis: Significance of Early Secreted Antigenic Target 6–Specific T Cell Depletion after HIV-1 Infection
Geldmacher C, Heinrich N, Koup RA, Hoelscher M
Correspondence, J Infect Dis. 2009:200 (1 July)
Early Depletion of Mycobacterium tuberculosis–Specific T Helper 1 Cell Responses after HIV-1 Infection
Geldmacher C, Schuetz A, Ngwenyama N, Casazza JP, Sanga E, Saathoff E, Boehme C, Geis S, Maboko L, Singh M, Minja F, Meyerhans A, Koup RA, and Hoelscher M
J Infect Dis. 2008 Dec 1;198(11):1590-8
A high viral burden predicts the loss of CD8 T-cell responses specific for subdominant gag epitopes during chronic human immunodeficiency virus infection
Geldmacher C, Gray C, Nason M, Currier JR, Haule A, Njovu L, Geis S, Hoffmann O, Maboko L, Meyerhans A, Cox J, Hoelscher M
J Virol. 2007 Dec; 81(24):13809-15.
CD8 T-cell recognition of multiple epitopes within specific Gag regions is associated with maintenance of a low steady-state viremia in human immunodeficiency virus type 1-seropositive patients
Geldmacher C, Currier JR, Herrmann E, Haule A, Kuta E, McCutchan F, Njovu L, Geis S, Hoffmann O, Maboko L, Williamson C, Birx D, Meyerhans A, Cox J, Hoelscher M
J Virol. 2007 Mar; 81(5):2440-8.
In a mixed subtype epidemic, the HIV-1 Gag-specific T-cell response is biased towards the infecting subtype
Geldmacher C, Currier JR, Gerhardt M, Haule A, Maboko L, Birx D, Gray C, Meyerhans A, Cox J, Hoelscher M
AIDS. 2007 Jan 11; 21(2):135-43.
